Prognostic factors in conversion surgery following nab‐paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual‐center study

BACKGROUND: In pancreatic ductal adenocarcinoma (PDAC), only radical surgery improves long‐term survival. We focused on surgical outcome after induction gemcitabine along with nab‐paclitaxel (GnP) and subsequent chemoradiotherapy (CRT) with S‐1 administration for unresectable locally advanced (UR‐LA...

Descripción completa

Detalles Bibliográficos
Autores principales: Igarashi, Takamichi, Yamada, Suguru, Hoshino, Yui, Murotani, Kenta, Baba, Hayato, Takami, Hideki, Yoshioka, Isaku, Shibuya, Kazuto, Kodera, Yasuhiro, Fujii, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831906/
https://www.ncbi.nlm.nih.gov/pubmed/36643365
http://dx.doi.org/10.1002/ags3.12613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831906/
https://www.ncbi.nlm.nih.gov/pubmed/36643365
http://dx.doi.org/10.1002/ags3.12613

Ejemplares similares